Indonesian medical workers get booster shots amid record-high Covid-19 cases straitstimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from straitstimes.com Daily Mail and Mail on Sunday newspapers.
Download 13.70 MB
The covid-19 vaccination rollout has been thrown into chaos after the Technical Advisory Group on Immunisation advised against the use of the Astra-Zeneca vaccine for Australians under the age of 50.
European and British regulators have found a link between the vaccine and extremely rare, but severe blood clots in younger people given the vaccine.
The federal government has ordered an additional 20 million doses of the Pfizer vaccine, but it s not clear how much the change will delay the rollout.
Guest: Federal Health Minister Greg Hunt
Duration: 14min 57sec
Clotting case shows we need compensation scheme for vaccine injuries
We’re sorry, this service is currently unavailable. Please try again later.
Dismiss
April 7, 2021 3.39pm
Normal text size
Advertisement
Vaccines against COVID-19 will prevent millions of deaths and hospitalisations, as early signs from Britain and Israel indicate. The savings for economies are likely to be in the trillions. The benefits are undeniable but vaccines also bring risks. Some are well described, such as feeling unwell in the day or so after receiving a COVID-19 vaccine, or the rare but treatable severe allergic reaction called anaphylaxis.
It appears increasingly likely that the AstraZeneca vaccine may cause a new rare clotting condition called “Suspected Vaccine Induced Prothrombotic Immune Thrombocytopenia”. VIPIT is a serious condition that presents as blood clots with low blood platelets (thrombocytopenia). The condition develops between four and 20 days after receiving the AstraZeneca